Research progress of neoadjuvant therapy for hepatocellular carcinoma
10.3760/cma.j.cn113884-20210813-00265
- VernacularTitle:肝细胞癌新辅助治疗策略的研究进展
- Author:
Shangjun DAI
1
;
Linqiang LI
;
Lianxin LIU
Author Information
1. 哈尔滨医科大学附属第一医院肝脏外科，哈尔滨 150001
- Keywords:
Carcinoma, hepatocellular;
Chemotherapy, adjuvant;
Radiotherapy
- From:
Chinese Journal of Hepatobiliary Surgery
2021;27(12):947-950
- CountryChina
- Language:Chinese
-
Abstract:
Primary liver cancer is one of the most common malignant tumors in the world, and it is also the main cause of cancer-related death. However, the recurrence rate after surgical resection is still high. These problems have led to the development of more neoadjuvant treatment strategies aimed at improving the prognosis and reducing the recurrence rate. Despite the lack of high-level evidence to guide treatment decisions, recent advances in local and systemic therapies, including radiotherapy and immunotherapy, raise the prospect of new approaches that may improve outcomes in hepatocellular carcinoma patients.
